Asm. Anna Kelles

Relates to creating the health emergency response data system, which collects information and statistical data relating to public health emergencies in order to assist the department of health, other government entities, health care providers, and the public in understanding and responding to public health emergencies.

Maddy summaryThis bill allows licensed health providers to deliver remote health services (telehealth) to students within schools. It specifically authorizes school-based health, dental, and mental health clinics and telehealth providers to offer these services during school or non-school hours, requiring them to meet state licensing standards and follow new regulations. The bill mandates that schools cannot charge for these services (funding comes from federal/state/local sources), requires parental consent for student care, and ensures telehealth supplements rather than replaces school nurses and counselors. It also sets requirements for privacy technology, staffing, and billing through new state regulations.

Maddy summaryThis bill requires local social services districts to set shelter allowances at up to 100% of the U.S. Department of Housing and Urban Development's (HUD) fair market rent (FMR) for a recipient's unit size in their district. It directly affects low-income housing recipients who receive shelter assistance through local social services districts. The key provision mandates that allowances cover the recipient's actual rent obligation, capped at HUD's current FMR for their specific area and unit size. This change ensures assistance aligns with local rental market rates rather than fixed or lower rates. The bill takes effect 30 days after enactment.

Prohibits the search, with or without a warrant, of geolocation and keyword data of a group of people who are under no individual suspicion of having committed a crime, but rather are defined by having been at a given location at a given time or searched particular words, phrases, character strings, or websites.

Establishes the civil right to counsel in eviction proceedings in New York state; creates the New York state office of civil representation; requires that covered individuals be given notice of such right to counsel.

Enacts the lift our communities advertise locally (LOCAL) program which provides a tax credit on advertising for locally owned minority-owned and women-owned business enterprises, certified service-disabled veteran-owned business enterprises or a small business.

Increases personal needs allowance amounts for individuals who are deemed eligible; requires that payments be subject to an annual adjustment reflecting the latest consumer price index, all items-U.S. city average.

Directs the commissioner of health to contract with an independent entity to conduct a comprehensive assessment of the existing methodology used to determine payment for early intervention screenings, evaluations, services and service coordination; directs recommendations on reimbursement methodology as well as needs under the program.

Relates to establishing an early intervention loan repayment program; provides funding is to be awarded regionally with 50% percent awarded to providers with a principal residence within NYC and the remaining fifty percent awarded to providers outside of NYC; provides that awards shall be given to providers who work in underserved areas for 3 consecutive years; provides loans shall be paid over a 3 year period; provides that a working group shall be established within 90 days to develop plans for the streamlined loan repayment program application process.

Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.